Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 786 of 6351
-
Can a flash of radiation tame melanoma skin lesions?
Symptom relief CompletedThis prospective single center phase I trials aims to assess feasibility and safety of electron FLASH RT for treatment of melanoma skin metastases. Feasibility will be defined as FLASH delivery with an accuracy of +/-10% for each fraction, safety will be confirmed if a maximum of…
Sponsor: University of Zurich • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Simple mouth swab could spot hidden throat cancer early
Diagnosis Recruiting nowInvestigators seek to determine the sensitivity and specificity of a combined HPV 16 DNA and host gene methylation oral biomarker panel to distinguish early Oropharyngeal Cancer (OPC) cases from controls among 100 early and 100 late disease pre-treatment OPC cases, and 200 contro…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis phase III trial tests the side effects of stereotactic body radiation therapy (SBRT) compared to hypofractionated radiotherapy for treating patients with prostate adenocarcinoma that has come back after a period of improvement (recurrent) or that has spread from where it fir…
Phase 3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for rare ovarian cancer: immunotherapy combo tested in phase II trial
Disease control Recruiting nowMulticenter, randomized, open-label, phase II clinical study comparing Dostarlimab +/- Bevacizumab with standard chemotherapy in patients with gynecological clear cell carcinoma. 198 subjects will be enrolled in this study and will be assigned to three groups in a 1:1:1 ratio. …
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Targeted radiation zaps glioblastoma cells after surgery
Disease control OngoingLocoregional, intracavitary radioimmunotherapy (iRIT) with a newly developed radioimmunoconjugate (Lu-177 labeled 6A10-Fab-fragments) will be used to prevent or postpone tumour recurrence in patients with GBM following standard therapy . Following study objectives will be analyz…
Phase 1 • Sponsor: University Hospital Muenster • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New study aims to personalize eating disorder treatment using smartphone data
Symptom relief Recruiting nowEating disorders (EDs) are serious mental illness: someone dies of an ED every 52 minutes. EDs are highly related to a host of negative outcomes, including public health and individual disease burden, medical and psychological comorbidities, and social determinants of health (SDO…
Sponsor: University of Louisville • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Which ketamine works better for severe depression? a 5-Year study aims to find out
Knowledge-focused Recruiting nowThis observational protocol is intended to provide long-term follow-up data on patients initiating or continuing treatment with either Spravato® or IV ketamine. This can provide us information on the patient acceptability and satisfaction, patterns of use, long-term effectiveness…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New hope for Platinum-Resistant ovarian cancer: RC88 shows promise in early trial
Disease control CompletedThe purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of RC88 monotherapy in subjects with Platinum-Resistant Recurrent Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer.
Phase 2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a common diabetes drug help delay preterm birth in preeclampsia?
Disease control Recruiting nowPreterm preeclampsia is a severe condition for both the mother and the fetus. Currently, the only treatment available to stop disease progression is termination/delivery of the fetus and placenta. Therefore, preterm preeclampsia carries the highest rates of neonatal morbidity and…
Phase 3 • Sponsor: Lina Bergman • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a pill keep vitiligo at bay? new study aims to find out
Disease control OngoingThis study is to evaluate how safe and effective ritlecitinib is in participants with non-segmental vitiligo (NSV). Ritlecitinib is studied in patients with non-segmental vitiligo. Vitiligo is a chronic acquired depigmentation disorder characterized by well-defined pale white pa…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Hope for kids with severe colitis: new drug trial shows promise
Disease control OngoingThe purpose of this study is to evaluate the efficacy of guselkumab in pediatric participants with moderately to severely active ulcerative colitis at the end of maintenance therapy among participants who were induction responders.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug aims to shrink hard-to-treat HER2 cancers
Disease control Recruiting nowPhase Ib: Explore the safety and tolerability of BL-M07D1 to further define RP2D in a variety of solid tumors, including locally advanced or metastatic urinary and gastrointestinal tumors. Phase II: To explore the efficacy of BL-M07D1 in patients with a variety of solid tumors in…
Phase 1/2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New vaccine V116 aims to shield vulnerable kids from pneumococcal disease
Vaccine CompletedThe purpose of this study is to evaluate the safety, tolerability, and immunogenicity of V116 compared to PPSV23 in children and teenagers 2 through 17 years of age, who had completed routine pneumococcal vaccine as infants/toddlers. Researchers want to learn if V116 is as good a…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Vaccine
Last updated Jun 27, 2026 11:00 UTC
-
Experimental enzyme shot aims to rescue kidneys in sepsis patients
Disease control CompletedThe purpose of this Ph2b study is to characterize the dose-response relationship and to evaluate the safety and efficacy of three different single doses of TIN816 in hospitalized adult participants in an intensive care setting with a diagnosis of sepsis-associated acute kidney in…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New meningitis vaccine shows promise in vietnam trial
Vaccine CompletedThe MEQ00074 study was a Phase III, open-label, single-center study aimed at describing the immunogenicity and safety of a single dose of investigational quadrivalent Meningococcal Polysaccharide (serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine (MenACYW conjugate vacc…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 26, 2026 17:46 UTC
-
Blood test could spot colon cancer early – 12,000 volunteers needed
Diagnosis Recruiting nowTo evaluate the performance characteristics of Signal-C™ a plasma circulating free-DNA test, to detect colorectal cancer and advanced precancerous lesions (APL) in an average risk screening population for 45 and over.
Sponsor: Universal Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Can a Blood-Based injection and botox ease jaw joint pain?
Disease control CompletedAim of Study : To evaluate the efficacy of TMJ arhtrocentesis followed by injection of liquid platelet rich fibrin (I-PRF ) in addition to intramuscular injection of lateral pterygoid muscle with botulinum toxin on clinical outcomes of painful TMJ , maximum mouth opening , joint …
Sponsor: Fayoum University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for Hard-to-Treat lung cancer: targeted drug combo trial launches
Disease control Recruiting nowThe purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors as a monotherapy or combined with Standard(s) of Care (SOC) or with each other. The first four subprotocols include t…
Phase 1/2 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a kidney drug be the next breakthrough for heart failure?
Disease control Recruiting nowFinerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricular ejection fraction.
Phase 3 • Sponsor: Colorado Prevention Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Promising drug combo aims to shrink breast tumors before surgery
Disease control OngoingThis is a multi-center, open-lable, prospective, randomized phase III clinical trial to further validate the efficacy and safety of neoadjuvant pyrotinib combined with chemotherapy in HR-positive/HER2-low (IHC 2+/FISH-negative) high-risk early breast cancer
Phase 3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC